Literature DB >> 18845821

Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.

J Färber1, K-A Moder, F Layer, I Tammer, W König, B König.   

Abstract

Infections caused by extended-spectrum beta-lactamase (ESBL)- and ampC beta-lactamase-producing gram-negative bacteria complicate therapy and limit treatment options. Several different panels for ESBL detection with automated systems exist. In addition, a chromogenic agar medium is available for ESBL screening. We compared two automated identification and susceptibility testing systems with regard to their effectiveness in detecting ESBL production in Enterobacteriaceae: the BD Phoenix system (BD Diagnostic Systems, Sparks, MD) and the Vitek 2 system (bioMerieux, Marcy l'Etoile, France). We tested 114 strains using the Etest as the standard, various available panels for both automated systems (for BD Phoenix, the NMIC/ID-50 and NMIC/ID-70 GN Combo panels for combined identification and susceptibility testing of gram-negative bacilli, and for Vitek 2, the ID-GNB panel for identification of gram-negative bacilli and the AST-N020, AST-N041, and AST-N062 panels for susceptibility testing), and a chromogenic agar medium (bioMérieux, Marcy l'Etoile, France). PCR for common ESBL gene families (encoding TEM, SHV, OXA, and CTX-M) and for chromosomal or plasmid-mediated ampC beta-lactamase genes was conducted to complete the study design. For the tested specimens overall, the chromID ESBL agar showed the highest sensitivity (95.8%) but the lowest specificity (10.5%) compared to the sensitivity and specificity of the Etest (chosen as reference by the authors) for the detection of ESBL-producing strains. The BD Phoenix system showed sensitivities of 77.1% and 84.2% and specificities of 61.5% and 75.0%, respectively, for the NMIC/ID-50 andNMIC/ID-70 panels. The sensitivity of the Vitek 2 system ranged from 78.8% (AST-N020) to 80.6% (AST-N062) and up to 84.2% (AST-N041). The specificities of the respective panels were 50.0% (AST-N041 and AST-N062) and 55.6% (AST-N020). In conclusion, the sensitivities and specificities of ESBL detection by the different methods differ depending on the microorganisms under study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845821      PMCID: PMC2576589          DOI: 10.1128/JCM.00777-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital.

Authors:  J C Lucet; D Decré; A Fichelle; M L Joly-Guillou; M Pernet; C Deblangy; M J Kosmann; B Régnier
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

2.  Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.

Authors:  Sylvain Brisse; Stefania Stefani; Jan Verhoef; Alex Van Belkum; Peter Vandamme; Wil Goessens
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

Authors:  Laurent Poirel; Marek Gniadkowski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

5.  Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.

Authors:  Maurine A Leverstein-van Hall; Ad C Fluit; Armand Paauw; Adrienne T A Box; Sylvain Brisse; Jan Verhoef
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

6.  Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals.

Authors:  J Barry; A Brown; V Ensor; U Lakhani; D Petts; C Warren; T Winstanley
Journal:  J Antimicrob Chemother       Date:  2003-04-14       Impact factor: 5.790

7.  Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method.

Authors:  Maurizio Sanguinetti; Brunella Posteraro; Teresa Spanu; Daniela Ciccaglione; Lucio Romano; Barbara Fiori; Giuseppe Nicoletti; Stefania Zanetti; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

8.  Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci.

Authors:  Marco Ligozzi; Cinzia Bernini; Maria Grazia Bonora; Maria De Fatima; Jessica Zuliani; Roberta Fontana
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

Review 9.  Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

Authors:  D L Paterson; W C Ko; A Von Gottberg; J M Casellas; L Mulazimoglu; K P Klugman; R A Bonomo; L B Rice; J G McCormack; V L Yu
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

10.  Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates.

Authors:  Enno Stürenburg; Ingo Sobottka; Heinz-Hubert Feucht; Dietrich Mack; Rainer Laufs
Journal:  Diagn Microbiol Infect Dis       Date:  2003-01       Impact factor: 2.803

View more
  14 in total

1.  Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods.

Authors:  G Valenza; S Müller; C Schmitt; D Turnwald; T-T Lam; M Frosch; M Abele-Horn; Y Pfeifer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-27       Impact factor: 3.267

Review 2.  Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae.

Authors:  Muriel Gazin; Fabienne Paasch; Herman Goossens; Surbhi Malhotra-Kumar
Journal:  J Clin Microbiol       Date:  2012-01-18       Impact factor: 5.948

3.  Colorimetric-plate method for rapid disk diffusion susceptibility testing of Escherichia coli.

Authors:  Sehnaz Sener; Ibrahim Cagatay Acuner; Yuksel Bek; Belma Durupinar
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

Review 4.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Rectal Carriage of Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Selective Preenrichment Increases Yield of Screening.

Authors:  M F Q Kluytmans-van den Bergh; C Verhulst; L E Willemsen; E Verkade; M J M Bonten; J A J W Kluytmans
Journal:  J Clin Microbiol       Date:  2015-05-20       Impact factor: 5.948

6.  Evaluation of Brilliance ESBL agar, a novel chromogenic medium for detection of extended-spectrum-beta- lactamase-producing Enterobacteriaceae.

Authors:  Te-Din Huang; Pierre Bogaerts; Catherine Berhin; Amelie Guisset; Youri Glupczynski
Journal:  J Clin Microbiol       Date:  2010-04-21       Impact factor: 5.948

7.  Impact of minimal inhibitory concentration breakpoints on local cumulative bacterial susceptibility data and antibiotic consumption.

Authors:  Sofia Stokkou; Ina Tammer; Stefanie Zibolka; Christina Grabau; Gernot Geginat
Journal:  BMC Res Notes       Date:  2014-09-03

8.  Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infections.

Authors:  Banu Bayraktar; Süleyman Pelit; Mehmet Emin Bulut; Elif Aktaş
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-03-25

9.  Extended Spectrum beta-Lactamases among Gram-Negative Bacterial Isolates from Clinical Specimens in Three Major Hospitals in Northern Jordan.

Authors:  Raymond G Batchoun; Samer F Swedan; Abdullah M Shurman
Journal:  Int J Microbiol       Date:  2009-09-10

10.  Molecular Epidemiology of ESBL Genes and Multi-Drug Resistance in Diarrheagenic Escherichia Coli Strains Isolated from Adults in Iran.

Authors:  Sadegh Ghorbani-Dalini; Mohammad Kargar; Abbas Doosti; Pejman Abbasi; Meysam Sarshar
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.